Product Description

NOBIVAC® Canine 1-Pv has been shown to be effective for vaccination of healthy dogs 6 weeks of age or older against canine parvovirus.
-Protects against all known CPV strains, including CPV-2c2,3
-Contains CPV-2b, one of the most prevalent field strains of parvovirus
-First to publish data showing protection against CPV-2c challenge2
-Study showed no clinical signs of infection in vaccinated puppies after challenge with mixed CPV-2b and CPV-2c strains2
-High antigenic mass (titer), low passage vaccine protects against all field strains currently seen
-Multiple studies demonstrate the ability to override maternal antibodies1

WARNINGS:
• Contains gentamicin and thimerosal as preservatives.
• Vaccinate only healthy, non-parasitized dogs.
• Do not vaccinate pregnant bitches.
• The use of a biological product may produce anaphylaxis and or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
• The age at which maternal antibody for canine parvovirus no longer interferes with the development of active immunity varies according to the bitch’s titer and quantity of colostral antibodies absorbed by the puppy.